BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 21449634)

  • 1. Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.
    Wang J; Liao L; Tan J
    Expert Opin Biol Ther; 2011 Jul; 11(7):893-909. PubMed ID: 21449634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MSCs: Biological characteristics, clinical applications and their outstanding concerns.
    Si YL; Zhao YL; Hao HJ; Fu XB; Han WD
    Ageing Res Rev; 2011 Jan; 10(1):93-103. PubMed ID: 20727988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives.
    Liang X; Ding Y; Zhang Y; Tse HF; Lian Q
    Cell Transplant; 2014; 23(9):1045-59. PubMed ID: 23676629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult mesenchymal stem cells and their potency in the cell-based therapy.
    Das M; Sundell IB; Koka PS
    J Stem Cells; 2013; 8(1):1-16. PubMed ID: 24459809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.
    Du Z; Wei C; Yan J; Han B; Zhang M; Peng C; Liu Y
    Liver Transpl; 2013 Feb; 19(2):215-25. PubMed ID: 23193024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.
    Yi T; Song SU
    Arch Pharm Res; 2012 Feb; 35(2):213-21. PubMed ID: 22370776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating multipotent mesenchymal stromal cells generate factors that exert paracrine activities on exogenous MSCs: Implications for paracrine activities in bone regeneration.
    Li F; Whyte N; Niyibizi C
    Biochem Biophys Res Commun; 2012 Oct; 426(4):475-9. PubMed ID: 22960177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine?
    Bernardo ME; Pagliara D; Locatelli F
    Bone Marrow Transplant; 2012 Feb; 47(2):164-71. PubMed ID: 21478914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from genetically altered mesenchymal stem cells (MSCs): candidates for improved MSC-directed myocardial repair.
    Alfaro MP; Young PP
    Cell Transplant; 2012; 21(6):1065-74. PubMed ID: 22080676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cell insights: prospects in cardiovascular therapy.
    Chou SH; Lin SZ; Kuo WW; Pai P; Lin JY; Lai CH; Kuo CH; Lin KH; Tsai FJ; Huang CY
    Cell Transplant; 2014; 23(4-5):513-29. PubMed ID: 24816448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases.
    Sadan O; Melamed E; Offen D
    Expert Opin Biol Ther; 2009 Dec; 9(12):1487-97. PubMed ID: 19821796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cell therapy for heart disease.
    Gnecchi M; Danieli P; Cervio E
    Vascul Pharmacol; 2012 Aug; 57(1):48-55. PubMed ID: 22521741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.
    Doorn J; Moll G; Le Blanc K; van Blitterswijk C; de Boer J
    Tissue Eng Part B Rev; 2012 Apr; 18(2):101-15. PubMed ID: 21995703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment.
    MacFarlane RJ; Graham SM; Davies PS; Korres N; Tsouchnica H; Heliotis M; Mantalaris A; Tsiridis E
    Expert Opin Ther Targets; 2013 Mar; 17(3):243-54. PubMed ID: 23293906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
    Millard SM; Fisk NM
    Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc.
    Huang YC; Leung VY; Lu WW; Luk KD
    Spine J; 2013 Mar; 13(3):352-62. PubMed ID: 23340343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials.
    Wang LT; Ting CH; Yen ML; Liu KJ; Sytwu HK; Wu KK; Yen BL
    J Biomed Sci; 2016 Nov; 23(1):76. PubMed ID: 27809910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular Reparative Mechanisms of Mesenchymal Stem Cells for Retinal Diseases.
    Ding SLS; Kumar S; Mok PL
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.